HKSE - Delayed Quote HKD
3SBio Inc. (1530.HK)
At close: 3:59 PM GMT+8
Major Holders
| Breakdown | |
|---|---|
| 27.21% | % of Shares Held by All Insider |
| 24.33% | % of Shares Held by Institutions |
| 33.43% | % of Float Held by Institutions |
| 166 | Number of Institutions Holding Shares |
Top Institutional Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Vanguard International Stock Index-Total Intl Stock Indx | 25.31M | Jul 31, 2024 | 1.06% | 159,469,643 |
| Vanguard International Stock Index-Emerging Markets Stk | 23.4M | Jul 31, 2024 | 0.98% | 147,429,996 |
| iShares Core MSCI Emerging Markets ETF | 14.81M | Sep 30, 2024 | 0.62% | 93,280,952 |
| DFA Emerging Markets Core Equity Portfolio | 14.2M | Jul 31, 2024 | 0.59% | 89,447,402 |
| DFA Investment Dimensions-DFA Emerging Mkts Value | 6.03M | Jul 31, 2024 | 0.25% | 37,985,851 |
| DFA Emerging Markets Small Cap Series | 5.72M | Jul 31, 2024 | 0.24% | 36,039,151 |
| Old Westbury Small & Mid Cap Strategies Fund | 5.47M | Jul 31, 2024 | 0.23% | 34,449,761 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S. Index Fund | 3.63M | Jul 31, 2024 | 0.15% | 22,883,295 |
| Avantis Emerging Markets Equity ETF | 3.21M | Sep 30, 2024 | 0.13% | 20,216,700 |
| Avantis Emerging Markets Equity Fund | 2.84M | Aug 31, 2024 | 0.12% | 17,863,650 |
Related Tickers
9995.HK RemeGen Co., Ltd.
15.000
+1.35%
348150.KQ KoBioLabs, Inc
7,280.00
-0.27%
6955.HK Shandong Boan Biotechnology Co., Ltd.
9.230
+0.33%
2256.HK Abbisko Cayman Limited
3.860
+0.26%
2162.HK Keymed Biosciences Inc.
44.200
+0.11%
2157.HK Lepu Biopharma Co., Ltd.
3.090
-0.64%
2105.HK Laekna, Inc.
9.420
+7.53%
9966.HK Alphamab Oncology
3.820
+2.14%
1548.HK Genscript Biotech Corporation
12.680
-1.55%
1877.HK Shanghai Junshi Biosciences Co., Ltd.
14.520
+0.69%